The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics

By R. Roberts, Y. Geda, D. Knopman, R. Cha, V. Pankratz, Brad Boeve, R. Ivnik, E. Tangalos, R. C. Petersen, Walter A. Rocca. Neuroepidemiology, 2008

797 citations recorded by the source corpus.

Subfields: Molecular Biology, Psychiatry and Mental health, Surgery

View Paper: https://www.semanticscholar.org/paper/9fe2e03c58170534fae6d0f83c98cb7ba70e4c76

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Arthur W. Toga
2. John Q. Trojanowski
3. William J. Jagust
4. Ronald C. Petersen
5. Clifford R. Jack Jr.

In Psychiatry and Mental health

1. Clifford R. Jack Jr.
2. Ronald C. Petersen
3. William J. Jagust
4. David S. Knopman
5. John Q. Trojanowski
6. P. Aisen
7. Prashanthi Vemuri
8. Christos Davatzikos

Citations in the corpus

• Normative Spatiotemporal Gait Parameters in Older Adults (2011, methodology): “Second, this study represents a secondary analysis of a population-based cohort study designed to investigate the prevalence, incidence and risk factors for dementia [12].”
• Defining imaging biomarker cut points for brain aging and Alzheimer's disease (2017, positive): “All clinically normal (CN) individuals in this study were participants enrolled in the Mayo Clinic Study of Aging (MCSA) [37].”
• The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception (2011, positive): “Epidemiological studies of participants aged 70 to 89 years who were nondemented found the prevalence of MCI in this population to be approximately 15%, with an approximate 2:1 ratio of two identified phenotypes, amnestic and nonamnestic [20,21].”